These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34164940)

  • 81. ROC analysis of p16 expression in cell blocks of metastatic head and neck squamous cell carcinoma.
    Wilson BL; Israel AK; Ettel MG; Lott Limbach AA
    J Am Soc Cytopathol; 2021; 10(4):423-428. PubMed ID: 33906829
    [TBL] [Abstract][Full Text] [Related]  

  • 82. High PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor in urothelial carcinoma.
    Zhong Q; Shou J; Ying J; Ling Y; Yu Y; Shen Z; Zhang Y; Li N; Shi Y; Zhou A
    Future Oncol; 2021 Aug; 17(22):2893-2905. PubMed ID: 34189951
    [TBL] [Abstract][Full Text] [Related]  

  • 83. In situ hybridization for high-risk HPV E6/E7 mRNA is a superior method for detecting transcriptionally active HPV in oropharyngeal cancer.
    Randén-Brady R; Carpén T; Jouhi L; Syrjänen S; Haglund C; Tarkkanen J; Remes S; Mäkitie A; Mattila PS; Silén S; Hagström J
    Hum Pathol; 2019 Aug; 90():97-105. PubMed ID: 31121191
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder.
    Aynaud O; Tranbaloc P; Orth G
    J Urol; 1998 Jan; 159(1):86-9; discussion 90. PubMed ID: 9400443
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.
    Chang A; Amin A; Gabrielson E; Illei P; Roden RB; Sharma R; Epstein JI
    Am J Surg Pathol; 2012 Oct; 36(10):1472-6. PubMed ID: 22982890
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Human papillomavirus-related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection.
    Ginori A; Barone A; Santopietro R; Barbanti G; Cecconi F; Tripodi SA
    Int J Urol; 2015 Feb; 22(2):222-5. PubMed ID: 25236950
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The study on relation of human papillomavirus and P53 expression with bladder transitional cell carcinoma.
    Chen T; Kong Q; Cao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Dec; 14(4):345-8. PubMed ID: 11471022
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma.
    Yang K; Hu H; Wu J; Wang H; Guo Z; Yu W; Yao L; Ding F; Zhou T; Wang W; Wang Y; Liu L; Guo J; Zhu S; Zhang X; Cao S; Lou F; Niu Y; Ye D; He Z
    Mol Cancer; 2023 Feb; 22(1):25. PubMed ID: 36739413
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Human papillomavirus is not an etiologic agent of urothelial inverted papillomas.
    Alexander RE; Davidson DD; Lopez-Beltran A; Montironi R; MacLennan GT; Compérat E; Idrees MT; Emerson RE; Cheng L
    Am J Surg Pathol; 2013 Aug; 37(8):1223-8. PubMed ID: 23681080
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder.
    Furihata M; Inoue K; Ohtsuki Y; Hashimoto H; Terao N; Fujita Y
    Cancer Res; 1993 Oct; 53(20):4823-7. PubMed ID: 8402668
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Tumour front inflammation and necrosis are independent prognostic predictors in high-grade urothelial carcinoma of the bladder.
    Hodgson A; Xu B; Satkunasivam R; Downes MR
    J Clin Pathol; 2018 Feb; 71(2):154-160. PubMed ID: 28768702
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Are bladder washing samples suitable for investigation of HPV infection in urinary bladder? Comparison in HPV prevalence between urine and washing samples.
    Nakagawa T; Shigehara K; Kato Y; Kawaguchi S; Nakata H; Nakano T; Izumi K; Kadono Y; Mizokami A
    J Med Virol; 2023 Jan; 95(1):e28110. PubMed ID: 36042577
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Early esophageal squamous cell carcinoma in a western series is not associated with active HPV infection.
    Kanaan C; Lorenzo D; Barret M; Audebourg A; Leblanc S; Chaussade S; Prat F; Terris B
    Virchows Arch; 2020 Nov; 477(5):697-704. PubMed ID: 32524184
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A four-antibody immunohistochemical panel can distinguish clinico-pathological clusters of urothelial carcinoma and reveals high concordance between primary tumor and lymph node metastases.
    Bontoux C; Rialland T; Cussenot O; Compérat E
    Virchows Arch; 2021 Apr; 478(4):637-645. PubMed ID: 33128085
    [TBL] [Abstract][Full Text] [Related]  

  • 96. MCM4 expression is associated with high-grade histology, tumor progression and poor prognosis in urothelial carcinoma.
    Kobayashi G; Hayashi T; Sentani K; Uraoka N; Fukui T; Kido A; Katsuya N; Ishikawa A; Babasaki T; Sekino Y; Nose H; Arihiro K; Hinata N; Oue N
    Diagn Pathol; 2023 Sep; 18(1):106. PubMed ID: 37737200
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tissue S100/calgranulin expression and blood neutrophil-to-lymphocyte ratio (NLR) in dogs with lower urinary tract urothelial carcinoma.
    Weinekötter J; Gurtner C; Protschka M; von Bomhard W; Böttcher D; Schlinke A; Alber G; Rösch S; Steiner JM; Seeger J; Oechtering GU; Heilmann RM
    BMC Vet Res; 2022 Nov; 18(1):412. PubMed ID: 36411489
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Tumor cell-based glycolytic metabolism and single-cell sequencing of urinary exfoliated cells for the diagnosis and molecular profiling of urothelial carcinoma].
    Xiao XY; Zhao H; Guo HQ; Wang C; Sun Y; Chang XX; Zhao LL; Zhang ZH
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):472-479. PubMed ID: 37106289
    [No Abstract]   [Full Text] [Related]  

  • 99. Utility of GATA-3 and associated immunohistochemical markers in the differential diagnosis of poorly differentiated urothelial carcinoma.
    Naik M; Rao BV; Challa S; Fonseca D; Sudha SM; Giridhar A; Sharma R; Raju KVVN; Rao TS
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147963
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Expression of Eukaryotic Translation Initiation Factors in the Urothelial Carcinoma of the Bladder.
    Luzha J; Nass N; Czapiewski P; Schroeder N; Kalinski T; Schostak M; Schatz C; Jandrig B; Haybaeck J
    Anticancer Res; 2023 Apr; 43(4):1437-1448. PubMed ID: 36974813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.